These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Field JJ, Fenske TS, Blinder MA. Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724 [Abstract] [Full Text] [Related]
38. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia]. Meili EO, Dazzi H, von Felten A. Schweiz Med Wochenschr; 1995 Mar 04; 125(9):405-11. PubMed ID: 7892567 [Abstract] [Full Text] [Related]
39. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine. Ambriz Fernandez R, Quintana Gonzalez S, Martinez Murillo C, Dominguez Garcia V, Rodriguez Moyado H, Collazo Jaloma J. Arch Med Res; 1996 Mar 04; 27(1):15-8. PubMed ID: 8867361 [Abstract] [Full Text] [Related]
40. [Prostate carcinoma associated spontaneous factor VIII:C inhibitor hemophilia. Successful therapy of severe hemorrhagic complication with porcine factor VIII in a 75-year-old patient]. Orth T, Schnütgen M, Herr W, Mayet WJ, Dippold W, Wanitschke R, Meyer zum Buschenfelde KH. Med Klin (Munich); 1997 Apr 15; 92(4):241-5. PubMed ID: 9221309 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]